This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. Pancreatic cancer is lethal due to lack of perceptible symptoms and effective treatment methods. Immunotherapy may provide promising therapeutic choices for malignant tumors like pancreatic cancer. Tumor-infiltrating lymphocytes (TIL) in tumor mesenchyme could recognize peptide antigens presented on the surface of tumor cells. The present study aimed to test the relationship between the T cell receptor (TCR) β repertoire of the tumor and peripheral blood, and also to investigate the intratumor spatial heterogeneity of the TCR β repertoire in pancreatic cancer. To the best of our knowledge, this is the first study to evaluate the clonal composition of TCR β repertoire in TIL across the spatial extent of pancreatic cancer. In this study, we studied 5 patients who were diagnosed with primary pancreatic cancer. Ultra-deep sequencing was used to assess the rearrangement of the TCR β-chain (TCR β) gene. HE staining and immunohistochemistry of CD3, CD4, CD8 and HLA class I were used to show histopathology and immune conditions macroscopically. TIL repertoire showed that different regions of the same tumor showed a greater number of repertoire overlaps between each other than between peripheral blood, which suggested that T cell clones in pancreatic cancer might be quite different from those in peripheral blood. In contrast, intra-tumoral TCR β repertoires were spatially homogeneous between different regions of a single tumor tissue. Based on these results, we speculated that the cellular adaptive immune response in pancreatic cancer was spatially homogeneous; this may pave the way for immunotherapy for the treatment of pancreatic cancer patients.
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| INTRODUC TI ON
The clonal composition of TIL can be assessed by analyzing the TIL repertoires generated by somatic recombination of the T cell receptor (TCR) α-and β-chains. Rearrangement of the V (variable), D (diversity), and J (joining) segments of the TCR β chain generates the highly variable complementary determining region 3 (CDR3), which is critical for determination of the specificity of each T cell clone.
16
Therefore, ultra-deep sequencing of the TCR β CDR3 region might help in approximately assessing the clonal composition of TIL.
In addition, T cell infiltrates might be uniform or heterogeneous across different regions of the same tumor. The heterogeneity is probably driven by intra-tumoral competition and selection by the host's immune response to tumor therapeutics. 17, 18 Figure S1 . For each patient, the sample named "T1" was taken from the center of the entire tumor tissue, and the other samples were taken from the surrounding areas. Peripheral blood was drawn at the time of surgery into EDTA-coated tubes prior to administration of anesthesia.
| MATERIAL S AND ME THODS

| Patients and samples
DNA was extracted from fresh tumor tissues using the EasyPure Genomic DNA Kit (Transgen Biotech, Beijing, China), and DNA from blood cells was isolated using the Whole Blood Genomic DNA Kit (BioTeke Corporation, Beijing, China) following the manufacturer's instructions. Moreover, ultra-deep TCR sequencing allows the analysis of the T cell repertoire using DNA extracted from samples without prior separation of the T cell population. Table 1 shows the details and number of samples from each patient. DNA from the 4 tumor samples from patient 1 was amplified using PCR 
| High-throughput sequencing
The TCR β CDR3 region was amplified using Multiplex PCR to obtain the region of the antigen receptor gene, and the TCR β CDR3 region was sequenced using Illumina NextSeq 500 (MyGenostics, Beijing, China). Sequencing reads were identified according to the definition established by the International ImMunoGeneTics (IMGT) collaboration. 23 Sequencing reads that did not match the canonical structure of CDR3 sequences were not used for subsequent analysis. A standard algorithm was used to identify which V, D and J segments contributed to each TCR β CDR3 sequence.
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| CDR3 sequence analysis
To evaluate the similarity between the TCR β repertoires of samples within the same tumor and between those of the tumor and peripheral blood, we used the metric of TCR β repertoire overlap.
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For example, for 2 samples, a and b, we identified n as TCR β CDR3 sequences present in both samples, and C as the sequencing read counts for each sequence in each sample. Meanwhile, the TCR β repertoire overlap was defined as the sum of the sequencing reads of shared TCR β sequences in both samples divided by the sum of sequencing reads observed in these 2 samples, which ranged from 0 to 1. The formula used for calculation is: F I G U R E 1 Diagram showing our experimental program. Four or five different regions of 1 single tumor were collected immediately after surgical resection. Peripheral blood was drawn at the time of surgery into EDTA-coated tubes prior to anesthesia. DNA from both tumor tissue and peripheral blood was extracted for T cell receptor (TCR) repertoire sequencing. Ultra-deep TCR sequencing allows the analysis of the T cell repertoire directly from DNA extracted from samples without prior separation of the T cell population. We divided each tumor tissue into 2 parts, 1 for DNA extraction and the other for immediate formalin fixation. These samples were used for HE staining and immunohistochemistry of CD3, CD4, CD8 and HLA class I
To convert the overlap metric into a distance metric, we defined it as follows:
The distance metric ranged from 0 to infinity. For clustering analysis, the TCR β sequence distance was used to construct a neighborjoining tree using the MEGA7 software. 24, 25 To quantify the diversity of T cell clones in the samples, we used the concept of clonality, which could provide diversity measurement as a function of the distribution of clone frequencies in each sample.
Clonality was calculated as 1 − (Shannon's entropy)/log2 (number of productive unique sequences). The clonality score of a maximally diverse population and a completely monoclonal population would be 0 and 1, respectively. 26, 27 During analysis of the sequencing results, the sequences that contained stop codons or frameshifts in the CDR3 region were unlikely to be functional; therefore, they were not used for subsequent analysis. In addition, the human T cell repertoire can be highly complex. Thus, the total number of unique T cell clones could be much higher than the sequencing depth used in the present study, 28 and this could result in the failure to detect low-frequency T cell clones, which might lead to an overestimation of the heterogeneity of the T cell repertoire between samples. 29 Therefore, to avoid the impact of low-frequency clone sampling bias, we only analyzed the top 100 T cell clones which were detected at the highest frequency in all samples. Furthermore, to verify the results for the top 100 T cell clones, we also evaluated the top 50 T cell clones detected at the highest frequency in all samples, and the results of the 2 types of analysis were similar (shown in Figures S2-S5 ).
| Immunohistochemistry
The 4-μm thick tissue sections were baked at 72°C for 1 hour, and then dewaxed in xylene and rehydrated in graded alcohol concentrations. Hydrogen peroxide (3%) was used to block the activity of endogenous peroxidase for 15 minutes. Antigen retrieval was performed in a pressure cooker after 3 PBS washes.
Upon cooling to room temperature, sections were blocked using corresponding blocking solution for 1 hour at 37°C. Then, the sections were incubated with the primary antibody at suitable dilutions overnight at 4°C. The following day, the ready-to-use EnVision regent (EnVision detection system peroxidase/DAB, rabbit/mouse; Dako, Glostrup, Denmark) was used to bind the primary antibody. 3.3′-Diaminobenzidine tetrahydrochloride (Dako, Glostrup, Denmark) was used to visualize the reaction. Then, the sections were counterstained with hematoxylin and dehydration was performed in the sequence of graded alcohol concentrations and xylene. The detailed experimental methods and information regarding the primary antibody are shown in Table S1 .
| Statistical analysis
Statistical analyses were performed using the SPSS software, version 13.0 (SPSS, Chicago, IL, USA). Unpaired t test and nonparametric tests were used depending on the category of data. A 2-sided P-value < .05 was considered statistically significant.
| RE SULTS
| High-throughput sequencing of T cells
We used Multiplex PCR to amplify the TCR β CDR3 region and then used high-throughput sequencing to examine the sequence of the TCR β CDR3 region. As shown in Table 2 in peripheral blood samples, respectively (unpaired t test, P < .001). The results of clonality which reflected the diversity of T cell clones showed that the TCR β repertoires of tumor tissues had fewer clonotypes than in their matched peripheral blood (average clonality was .55 in tumor tissues and average clonality was .49 in peripheral blood; P = .035 using the nonparametric test). These results showed that TCR β repertoires in pancreatic tumor tissues were more oligoclonal.
| Spatial homogeneity of T cell clones within a single tumor
We used the TCR β repertoire overlap and the distance metric to evaluate the heterogeneity or homogeneity among different tumor regions, and between the tumor and peripheral blood samples.
However, the noise inherently found in sampling randomly from a diverse population might cause random sampling error even if we only analyze the top 100 T cell clones. Thus, to evaluate the interference of sequencing error and sampling noise caused by sequencing, we performed duplicate PCR reactions in 4 tumor samples of patient 1. Using replicate PCR reactions, the only factor that influenced the TCR β overlap metric was technical error and sampling noise.
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As shown in Figure 2 , the TCR β repertoire overlap illustrated that different regions of the same tumor showed much more repertoire overlaps with each other than with peripheral blood. Moreover, dendrograms clearly show that peripheral blood was quite distant from tumor samples (shown in Figure 3 ). These results indicated that different tumor regions shared more TCR β sequences with each other than with corresponding peripheral blood.
We also compared the average TCR β overlap of duplicate sam- Figure 4 ; we found that the average TCR β overlaps of "T and T" were not significantly lower than
ples (Duplicate T), tumor tissues (T and T) and tumor tissues vs peripheral blood (T and B), as shown in
TCR β overlaps of "Duplicate T" (unpaired t test, P = .104), whereas there were significant differences in the average TCR β overlaps of "T and T" vs "T and B" (nonparametric test, P < .001), as well as in the average TCR β overlaps of "Duplicate T" vs "T and B" (unpaired t test, P = .001). These results demonstrated that the T cell response within pancreatic cancer was homogeneous across the spatial extent in 1 single tumor.
To further evaluate the degree of spatial heterogeneity of the T cell response in pancreatic cancer, we classified sequences into ubiquitous and heterogeneous sequences. Heat maps were constructed to show the frequencies of each ubiquitous and heterogeneous clone in each sample (shown in Figure 5 ). Heat maps for regional abundance of the top 100 T cell clones in all samples showed that T cell clones in different regions of a single tumor were spatially homogeneous, especially in clones with high frequencies. 
| HE
| D ISCUSS I ON
Immunotherapy is a novel method used in fundamental and clinical pancreatic cancer research. Some progress has been made, such as the development of adoptive T cell therapy. 30, 31 T cells can outcomes. [10] [11] [12] [13] [14] [15] In this study, to investigate the heterogeneity or homogeneity of TIL across different regions of the same tumor in pancreatic cancer, we evaluated the characteristics of TIL in primary pancreatic cancer using ultra-deep sequencing for the rearranged TCR β gene.
We This lymphocyte distribution feature was similar with some other diseases. [35] [36] [37] [38] There are also aspects to be improved in the present study. In summary, to the best of our knowledge, this is the first study to evaluate the clonal composition of TIL across the spatial extent of pancreatic cancer using high-throughput TIL repertoires, and we F I G U R E 6 The HE staining and representative immunohistochemical staining images of CD3, CD4, CD8 and HLA class I in patient 1 (magnification: ×200). CD3, CD4 and CD8 expression were localized mainly on the plasma membrane of T cells in the mesenchyme of the tumor tissue. Staining of CD3, CD4 and CD8 could roughly represent the quantity of T cells in the mesenchyme of tumor tissue. CD3, CD4 and CD8 expression were mostly seen scattered throughout the tumor while occasionally in clusters. HLA class I staining was seen in the tumor cell membrane and cytoplasm. Each tumor tissue showed moderate or strong expression of HLA class I have demonstrated that ultra-deep sequencing of the TCR gene allowed analysis of the TCR gene sequence using DNA directly extracted from pancreatic cancer tissues without prior separation of the T cell population. We found that the immune response in pancreatic cancer was distinct from the circulating immune repertoire, and that the intra-tumoral microenvironment was characterized by internally homogenous T cell repertoires. Therefore, a single biopsy of pancreatic cancer could provide sufficient information about the entire tumor. In future studies, we will also compare TCR repertoires in liver metastases or lymph node metastases with primary pancreatic cancer tissue, which could provide references for immunotherapy of advanced pancreatic cancer. A study referring to the TIL of pancreatic cancer has shown that pancreatic cancer is not an immunologically "cold" tumor; 43 thus, if a method is developed to isolate TIL specific for antigens of a random region of the tumor, the corresponding adoptive cell therapy may be efficient for patients, which might provide a novel method for immunotherapy to treat pancreatic malignancies.
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